Adcock Ingram : Trading statement

Adcock Ingram Holdings Limited

Incorporated in the Republic of South Africa (Registration number 2007/016236/06) Share code: AIP ISIN: ZAE000123436

("Adcock Ingram" or "the Company" or "the Group")

TRADING STATEMENT

In terms of the JSE Limited ("JSE") Listings Requirements, companies are required to provide guidance to the market when they are satisfied that a reasonable degree of certainty exists that the financial results for the current reporting period will differ by at least 20% from the results of the previous corresponding reporting period.

The Group's results for the financial year to June 2022 ("current period") are expected to show an improvement of at least 20% (79.3 cents) in earnings per share ("EPS") from the 396.3 cents reported for the year ended June 2021 ("comparative period"). Similarly, it is also expected to show an improvement of at least 20% (80.9 cents) in headline earnings per share ("HEPS") from the 404.7 cents reported for the comparative period. This is due to an improvement in the trading environment relative to the comparative period which had been adversely impacted by certain factors caused by the first wave of COVID-19. In this regard, the Company has experienced improved demand in the current period for its over-the-counter and consumer healthcare products

However, as the results are not yet finalised, Adcock Ingram cannot with reasonable certainty, quantify the extent of the improvement in its results for the current period within a range as required by the JSE Listings Requirements.

A further trading statement (as required by the JSE Listings Requirements) will be released on SENS as soon as the Company has a reasonable degree of certainty on the expected HEPS and EPS ranges for the current period.

The financial information on which this trading statement is based has not been reviewed and reported on by the Company's external auditors.

Midrand

15 July 2022

Sponsor

RAND MERCHANT BANK (a division of FirstRand Bank Limited)